The FDA is taking no prisoners as it continues its efforts to combat widespread GLP-1 drug compounding. | In the letters sent ...

Maybe if the health insurance and pharmaceutical industries weren’t such grifters, people wouldn’t have to turn to alternatives.” ...

The Food and Drug Administration (FDA) on Tuesday sent 30 telehealth companies warning letters about their “illegal” sales of ...

Novo Nordisk (NVO) stock gained 3% after FDA issued warning letters to 30 telehealth firms over false claims about compounded semaglutide and tirzepatide drugs.

The FDA announced a concerted action against direct-to-consumer (DTC) advertising of pharma products last September, and has since sent thousands of letters warning pharmaceutical and telehealth firms ...

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

Compounded GLP-1s for Weight Loss: What Are They and Are They Safe? GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably heard ...

Indiana lawmakers are weighing new guardrails around drug compounding amid warnings that patients are receiving powerful prescription treatments in settings that operate largely outside state ...

Does Compounded Semaglutide Work for Weight Loss? Compounded semaglutide can be an affordable alternative to brand-name weight loss injections like Ozempic and Wegovy. But it’s important to understand ...